Results of Scalp Cooling During Anthracycline-Containing Chemotherapy Depend on Scalp Skin Temperature
September 2016
in “
Breast
”
TLDR Cooler scalp temperatures during chemotherapy may prevent hair loss.
This study explored the relationship between scalp skin temperature and the effectiveness of scalp cooling in preventing chemotherapy-induced alopecia (CIA) in 62 breast cancer patients undergoing anthracycline-containing chemotherapy. The results indicated that the efficacy of scalp cooling was temperature-dependent, with the best outcomes observed when the scalp temperature decreased below 18°C. Specifically, 21% of patients did not require a wig or head covering, and these patients had a significantly lower mean scalp skin temperature (18°C) compared to those who experienced alopecia (20°C). The study concluded that achieving a scalp skin temperature of at least 18°C is crucial for the success of scalp cooling in preventing CIA.